Scholarlink

Background <p>Cutaneous squamous cell carcinoma (cSCC) is the second most common form of non-melanoma skin cancer (NMSC), with a steadily increasing global incidence, especially in populations with prolonged ultraviolet (UV) exposure. Advanced or metastatic cSCC carries a poor prognosis, while the application of targeted therapies and immunotherapies remains in the exploratory stage, due to limited understanding of the underlying mechanisms of cSCC occurrence and progression. Epigenetic dysregulation plays important roles in the progression of cSCC. However, how multi-dimensional regulatory networks reshape the epigenetic landscape and contribute to dysregulated gene expression in cSCC remains unclear.</p> Methods <p>In this study, we performed parallel RNA m<sup>6</sup>A sequencing, 850K DNA methylation arrays, whole transcriptome sequencing, and ATAC-seq chromatin accessibility profiling on samples from normal skin, actinic keratosis (AK), and cSCC. We analyzed the regulatory networks and pathways of epigenetic modifications on gene expression. We further explored the crosstalk of epigenetic regulatory networks by correlation analysis. By integrating single-cell RNA-seq data, we identified epigenetically upregulated candidate genes and confirmed their expression and functions with experimental methods.</p> Results <p>Our integrated multi-omics analysis provides a comprehensive and dynamic epigenetic map of cSCC progression. Further analysis revealed that DNA methylation and m<sup>6</sup>A modification jointly regulate gene expression through independent and synergistic ways. The identified epigenetically upregulated candidate genes <i>IDO1, IFI6</i>, and <i>OAS2</i> were validated to be overexpressed in cSCC tissues and cell lines, and functional assays confirmed their potential key roles in regulating the processes of cell proliferation, migration and invasion in cSCC.</p> Conclusions <p>By integrating multi-omics data, this study systematically highlights the multi-layered epigenetic alterations and regulatory mechanisms involved in cSCC development. This multi-stage, multi-omics, and multi-resolution integrated analysis provides a theoretical basis and new insights for future personalized treatment strategies for cSCC.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Multi-omics analysis reveals the crosstalk of epigenetic regulatory networks in cutaneous squamous cell carcinoma progression

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月13日

查看全文
  • Ya-Zhou Sun,
  • Dan-Dan Zou,
  • Xin-Jie Li,
  • Xiao-Li Wang,
  • Jia-Hao Feng,
  • Jia-Ying Liu,
  • Ke He,
  • Yu-Tong He,
  • Xian-Xin Lai,
  • Xin Li,
  • Xuan Jiang,
  • Tian-Shun Gao,
  • Li He

摘要

Background

Cutaneous squamous cell carcinoma (cSCC) is the second most common form of non-melanoma skin cancer (NMSC), with a steadily increasing global incidence, especially in populations with prolonged ultraviolet (UV) exposure. Advanced or metastatic cSCC carries a poor prognosis, while the application of targeted therapies and immunotherapies remains in the exploratory stage, due to limited understanding of the underlying mechanisms of cSCC occurrence and progression. Epigenetic dysregulation plays important roles in the progression of cSCC. However, how multi-dimensional regulatory networks reshape the epigenetic landscape and contribute to dysregulated gene expression in cSCC remains unclear.

Methods

In this study, we performed parallel RNA m6A sequencing, 850K DNA methylation arrays, whole transcriptome sequencing, and ATAC-seq chromatin accessibility profiling on samples from normal skin, actinic keratosis (AK), and cSCC. We analyzed the regulatory networks and pathways of epigenetic modifications on gene expression. We further explored the crosstalk of epigenetic regulatory networks by correlation analysis. By integrating single-cell RNA-seq data, we identified epigenetically upregulated candidate genes and confirmed their expression and functions with experimental methods.

Results

Our integrated multi-omics analysis provides a comprehensive and dynamic epigenetic map of cSCC progression. Further analysis revealed that DNA methylation and m6A modification jointly regulate gene expression through independent and synergistic ways. The identified epigenetically upregulated candidate genes IDO1, IFI6, and OAS2 were validated to be overexpressed in cSCC tissues and cell lines, and functional assays confirmed their potential key roles in regulating the processes of cell proliferation, migration and invasion in cSCC.

Conclusions

By integrating multi-omics data, this study systematically highlights the multi-layered epigenetic alterations and regulatory mechanisms involved in cSCC development. This multi-stage, multi-omics, and multi-resolution integrated analysis provides a theoretical basis and new insights for future personalized treatment strategies for cSCC.